BIND Therapeutics, Rusnano: The open joint stock company created and owned by the Russian government, Rusnano, just disclosed that it is purchasing shares of Bind Therapeutics Inc (NASDAQ:BIND). In a filing with the Securities and Exchange Commission, Rusnano reported ownership of 1,491,357 shares of Bind, which represent 9.28% of the company. The value of the stake amounts to some $22.64 million, at the current price of company’s stock. Rusnano reported that it acquired 120,000 shares from Bind’s IPO at the end of September. The value of the transaction amounted to $1.8 million.
Recommended Reading:
How Hedge Fund Manager Crispin Odey Feels About the US, UK and Europe
Ferrellgas Insider Buying Activity Heats Up
SC Fundamental Value Calls on Transcept Pharmaceuticals to Remove Four Board Members
